DEVAN PILLAY

DEVAN PILLAY

CEO

Pacific Medical Industries (PMI)

About me

Devan Pillay is CEO of PMI, one of the largest private pharmaceutical companies in Myanmar. He has worked in a number of different roles and geographies including South Africa, Singapore, Malaysia, Australia and now in Myanmar. Devan's experience ranges across chemical manufacturing, FMCG, Oil & Gas (lubricants) and Pharma. This is his second role as CEO having been previously the CEO of one of the largest joint-venture companies between Shell and BP in Africa. He has a degree in Mechanical Engineering and an MBA from the University of Cape Town.
Attendee Access type
Attendee
Country
Myanmar
Organization Type
Manufacturer/Innovator
Business Activity
Pharmaceutical Company (generic finished products)
Markets Active In
AfricaEast Asia (e.g., China, Japan, Korea)South East Asia (e.g., Tailand, Philippines, Singapore, e.t.c.)

About me (Individual)

Department
General Management
Job Function
CEO/COO/President/Chairman
Purchasing Responsibility
Authorise purchase
Geographical areas you plan to expand to:
OceaniaSouth Asia (e.g. India, Pakistan, Sri Lanka, e.t.c)South East Asia (e.g., Tailand, Philippines, Singapore, e.t.c.)

Offering/Interested In

Interested in: Business Type
API ProducerBiopharmaceuticalGeneric APIs producerPharmaceutical Company (innovator finished products)
Interested in: Company Type
Contract ServiceManufacturer/InnovatorWholesale/Retail
Interested In: Company Certification
GMPISO
Interested In: Product Certification
None

Interested In

Interested In: Products & Service Category
Finished Dosage Forms
Interested In: Finished Dosage Formulations
CapsulesCreams, Lotions, OintmentsGel CapsInjectablesPowdersTablets

Content

Company
PMI

Social media

Is member of

Pacific Pharmaceuticals PTE LTD
Cancelled Exhibitors
United Pharma Industries Co. Ltd
Exhibitors

is attending

From clinical data to manufacturing decisions: How AI is transforming Pharma forecasting

Wednesday, July 8, 2026 3:30 AM to 4:15 AM
ASEAN Connect Room (Hall 3)

Thailand Pharma Ecosystem: Regulatory pathways & market access in focus

Wednesday, July 8, 2026 6:00 AM to 7:00 AM
ASEAN Connect Room (Hall 3)

Doing Pharmaceutical Business in Malaysia: Market Landscape, Regulatory Pathways & Growth Opportunities

Wednesday, July 8, 2026 6:15 AM to 7:15 AM
Quality Excellence Room (Hall 2)

The Next Evolution of GLP-1: Oral Korglutide — A Dual GLP-1/IGF-1 Peptide for Fat Loss Without Muscle Loss

Wednesday, July 8, 2026 6:45 AM to 7:15 AM
Technical Seminar (Hall 2)

Log in

See all the content and easy-to-use features by logging in or registering!